Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

Bio-Rad Currently Expects 2023 Non-GAAP Revenue To Decline By Approximately 3.5% On Currency-Neutral Basis Vs. Previous Estimate Of 0.8% Revenue Growth

Author: Benzinga Newsdesk | October 26, 2023 04:47pm

Posted In: BIO